RAYNAUD'S PHENOMENON AND SYSTEMIC SCLEROSIS

被引：0
|
作者：
Denton, C. P. [1 ]
机构：
[1] UCL Med Sch, Ctr Rheumatol, London, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.6249
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SP0056
引用
收藏
页码：15 / 16
页数：2
相关论文
共 50 条
  • [21] Efficacy of cilostazol for the treatment of Raynaud's phenomenon in systemic sclerosis patients
    Negrini, Simone
    Spano, Francesca
    Penza, Elena
    Rollando, Daniela
    Indiveri, Francesco
    Filaci, Gilberto
    Puppo, Francesco
    CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 16 (03) : 407 - 412
  • [22] Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis
    Sunderkoetter, C.
    Riemekasten, G.
    RHEUMATOLOGY, 2006, 45 : 33 - 35
  • [23] Neuronal Regulators and Vascular Dysfunction in Raynaud's Phenomenon and Systemic Sclerosis
    Fonseca, Carmen
    Abraham, David
    Ponticos, Markella
    CURRENT VASCULAR PHARMACOLOGY, 2009, 7 (01) : 34 - 39
  • [24] The clinical relevance of Raynaud's phenomenon symptom characteristics in systemic sclerosis
    Hughes, Michael
    Huang, Suiyuan
    Pauling, John D.
    Sabbagh, Maya
    Khanna, Dinesh
    CLINICAL RHEUMATOLOGY, 2022, 41 (10) : 3049 - 3054
  • [25] Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis
    Thompson, AE
    Shea, B
    Welch, V
    Fenlon, D
    Pope, JE
    ARTHRITIS AND RHEUMATISM, 2001, 44 (08): : 1841 - 1847
  • [26] Treatment of severe Raynaud's phenomenon with bosentan in a patient with systemic sclerosis
    Dunne, J.
    Dutz, J.
    Shojania, K.
    Ng, B.
    van Eeden, S.
    RHEUMATOLOGY, 2006, 45 (07) : 911 - 912
  • [27] Efficacy of cilostazol for the treatment of Raynaud’s phenomenon in systemic sclerosis patients
    Simone Negrini
    Francesca Spanò
    Elena Penza
    Daniela Rollando
    Francesco Indiveri
    Gilberto Filaci
    Francesco Puppo
    Clinical and Experimental Medicine, 2016, 16 : 407 - 412
  • [28] The clinical relevance of Raynaud’s phenomenon symptom characteristics in systemic sclerosis
    Michael Hughes
    Suiyuan Huang
    John D Pauling
    Maya Sabbagh
    Dinesh Khanna
    Clinical Rheumatology, 2022, 41 : 3049 - 3054
  • [29] Sarpogrelate hydrochloride therapy for Raynaud'S phenomenon in patients with systemic sclerosis
    Ogawa, Takehiko
    Ogura, Takehisa
    Izumi, Yuichi
    Hirata, Ayako
    Hayashi, Norihide
    Miura, Reiko
    Morita, Shinobu
    Kujime, Rie
    Ogawa, Kana
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S821 - S822
  • [30] Bosentan therapy for patients with severe Raynaud's phenomenon in systemic sclerosis
    Hettema, M. E.
    Zhang, D.
    Bootsma, H.
    Kallenberg, C. G. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (10) : 1398 - 1399
12345